Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development
- PMID: 38506833
- DOI: 10.1001/jamadermatol.2024.0048
Improved Dermatologist, Patient, and Oncologist Collaboration Needed During Cancer Drug Development
Comment on
-
Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic Review.JAMA Dermatol. 2024 Jun 1;160(6):651-657. doi: 10.1001/jamadermatol.2024.0053. JAMA Dermatol. 2024. PMID: 38506826
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources